Research on Immune Response and Vaccines: 2nd Edition
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Innate and Adaptive Immunity in Vaccination".
Deadline for manuscript submissions: 30 April 2025 | Viewed by 66
Special Issue Editor
Interests: rheumatoid arthritis; inflammatory arthritis and biologic therapy; immune
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The importance of vaccination is clear with the emergence of the COVID-19 pandemic. However, even though researchers have been working on vaccines for decades, many diseases such as bacterial, fungal, parasitic and viral infections still don't have effective vaccines. The primary aim of vaccination is to generate a safe and effective long-term immune response against targeted diseases. Vaccines activate the immune system to produce memory T and B which will mount a rapid and robust response to antigens they have previously encountered, thus preventing the disease or reducing its severity when exposed to the pathogen later on.
In this Special Issue, we will gather research articles related to the efficacy and effectiveness of vaccines, vaccine failure, herd immunity, herd effect, and epidemiological transfer, specifically vaccine-related immune responses. We welcome research using both quantitative and qualitative methods, as well as contributions featuring under-researched populations.
Prof. Dr. James Galloway
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccines
- immunogenicity
- antigen recognition
- adaptive immunity
- cytokine response COVID-19
- influenza
- HPV
- tuberculosis (BCG)
- malaria
- HIV
